Lineage Cell Therapeutics (LCTX) Intangibles (2010 - 2026)
Lineage Cell Therapeutics (LCTX) recorded Intangibles of $31.7 million in Q2 2026, unchanged from $31.7 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Lineage Cell Therapeutics (LCTX) Intangibles (2010 - 2026) Analysis & Trends
Starting with Q4 2010, Lineage Cell Therapeutics' Intangibles history includes 62 quarters.
- Annual Intangibles has a five-year compound annual growth rate of -7.6% (FY2020 to FY2025).
- Across earlier years, Intangibles came in at $46.54 million in FY2024 (unchanged), $46.56 million in FY2023 (-0.3%), $46.69 million in FY2022 (-0.3%) and $46.82 million in FY2021 (-0.4%).
- Quarterly Intangibles has ranged from $31.7 million in Q2 2025 to $46.85 million in Q3 2021 over the past five years.
- The year-over-year decline in Intangibles has ranged between 0.0% (Q2 2026) and 31.9% (Q2 2025) over the last five years.
- Per Business Quant, the preceding three quarters came in at $31.7 million (Q1 2026), $31.7 million (Q4 2025) and $31.7 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 48.23 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 49.14 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 24.98 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 42.07 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 37.72 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 20.49 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 14.03 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 47.05 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 412.80 Mn |
| 10 | Lineage Cell Therapeutics | 242.79 Mn | 41.20 Mn | - | 31.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 31.70 Mn |
| Mar 31, 2026 | 31.70 Mn |
| Dec 31, 2025 | 31.70 Mn |
| Sep 30, 2025 | 31.70 Mn |
| Jun 30, 2025 | 31.70 Mn |
| Mar 31, 2025 | 46.54 Mn |
| Dec 31, 2024 | 46.54 Mn |
| Sep 30, 2024 | 46.54 Mn |
| Jun 30, 2024 | 46.54 Mn |
| Mar 31, 2024 | 46.54 Mn |
| Dec 31, 2023 | 46.56 Mn |
| Sep 30, 2023 | 46.59 Mn |
| Jun 30, 2023 | 46.63 Mn |
| Mar 31, 2023 | 46.66 Mn |
| Dec 31, 2022 | 46.69 Mn |
| Sep 30, 2022 | 46.72 Mn |
| Jun 30, 2022 | 46.76 Mn |
| Mar 31, 2022 | 46.79 Mn |
| Dec 31, 2021 | 46.82 Mn |
| Sep 30, 2021 | 46.85 Mn |
API Access
Lineage Cell Therapeutics Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=LCTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "LCTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=LCTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();